Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by narmacon Dec 31, 2022 9:19am
77 Views
Post# 35198269

RE:RE:RE:Midatech at $1.0475

RE:RE:RE:Midatech at $1.0475Hummm,,,,can anyone name a junior company which has issued over 1 Billion shares into the public markets that has actually made it in business down the road in reality??.......I can't think of one!!!,,,,maybe there are,,,,maybe!!,,,,,none of the companies I have followed or been invested in ever did,,,,,,they all failed and imploded,,,,,only the management personel involved made anything!!!

So,,,  here we are decades later and important water passing under our bridge, going from 80 Million shares to 1.17 billion shares and losing every bit of control and direction in the mean time. NOT looking good for sure. 7% ownership and less coming to us initially. The greedy wont be happy until we are <3%,,,,,between the reverse splits coming and the general dilution over the next few years, we will be an unknown within,,,,and that is if this new management team can stay abreast of the science and if any of the science actually works to the point of accreditation by any drug administration on the globe!!


<< Previous
Bullboard Posts
Next >>